Sartorius Stedim Biotech S.A. (LON:0RG8)

Sartorius Stedim Biotech Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16,431	15,185	19,155	24,732	37,348	24,050
Market Cap Growth	-32.44%	-20.72%	-22.55%	-33.78%	55.29%	108.47%
Enterprise Value	18,361	17,158	22,373	25,691	37,777	24,225
Last Close Price	168.88	154.43	206.48	270.79	408.40	258.27
PE Ratio	96.14	104.87	71.14	31.83	107.31	79.91
PS Ratio	6.87	6.61	7.95	7.98	15.40	14.05
PB Ratio	4.90	4.56	8.26	11.09	25.66	18.37
P/TBV Ratio	-	-	-	46.41	163.54	112.24
P/FCF Ratio	33.66	38.63	80.91	153.46	117.67	104.17
P/OCF Ratio	22.33	22.53	29.57	45.54	63.35	64.39
EV/Sales Ratio	7.53	7.46	9.29	8.29	15.58	14.16
EV/EBITDA Ratio	31.39	32.97	39.20	24.20	43.61	46.83
EV/EBIT Ratio	51.43	52.40	54.93	27.47	48.88	53.74
EV/FCF Ratio	37.61	43.65	94.51	159.41	119.02	104.93
Debt / Equity Ratio	0.73	0.71	1.38	0.45	0.36	0.40
Debt / EBITDA Ratio	4.23	4.38	5.39	0.93	0.60	1.00
Debt / FCF Ratio	5.03	6.04	13.50	6.25	1.66	2.28
Asset Turnover	0.34	0.35	0.43	0.78	0.85	0.81
Inventory Turnover	2.06	2.01	1.62	1.85	2.13	2.27
Quick Ratio	1.04	1.05	0.49	0.53	0.59	0.59
Current Ratio	1.85	1.85	1.51	1.61	1.40	1.54
Return on Equity (ROE)	5.25%	5.33%	12.05%	41.43%	25.94%	25.56%
Return on Assets (ROA)	3.19%	3.10%	4.59%	14.62%	16.90%	13.38%
Return on Capital (ROIC)	3.81%	3.74%	5.86%	21.93%	26.10%	18.63%
Return on Capital Employed (ROCE)	5.80%	5.40%	6.90%	26.20%	31.60%	22.00%
Earnings Yield	1.04%	0.95%	1.41%	3.14%	0.93%	1.25%
FCF Yield	2.97%	2.59%	1.24%	0.65%	0.85%	0.96%
Dividend Yield	0.29%	0.37%	0.29%	0.47%	0.26%	0.24%
Payout Ratio	32.84%	38.32%	42.77%	13.25%	15.13%	9.33%
Buyback Yield / Dilution	-3.64%	-5.01%	0.00%	0.01%	0.00%	-0.00%
Total Shareholder Return	-3.35%	-4.64%	0.29%	0.49%	0.26%	0.23%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.